Brain Cancer Clinical Trials in New York

Showing 81-100 of 236 trials

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

NCT03220646

The purpose of this study is to test any good and bad effects of a study drug called abemaciclib (LY2835219) in patients with recurrent brain tumors.

Brain Tumor

Memorial Sloan Kettering Cancer Center64 participantsStarted Jul 2017

Hartford, Connecticut, United States • Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States +5 more locations

Active Not RecruitingNA< 1 mile

Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma

NCT01892397

The purpose of this study is to find out what effects, good or bad, the Optune device has on the patient and meningioma. This study is being done because currently there are no proven effective medical treatments for a progressive meningioma that has failed surgery and/or radiation. The study uses an experimental device called Optune. Optune is "experimental" because it has not been approved by the U.S. Food and Drug Administration (FDA) for this type of tumor, although it has been approved for a different type of brain tumor.

Brain Cancer

Memorial Sloan Kettering Cancer Center6 participantsStarted Jun 2013

Los Angeles, California, United States • Denver, Colorado, United States • Miami, Florida, United States +6 more locations

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma

Brain Cancer Trials in Other Cities

Glioma Developmental and HyperActive Ras Tumor (DHART) Board

A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM

Brodalumab in the Treatment of Immune-Related Adverse Events

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma

Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma

Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)

REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma

A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

9-ING-41 in Pediatric Patients With Refractory Malignancies.

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

VB-111 in Surgically Accessible Recurrent/Progressive GBM

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma

Other Conditions in New York